For someone exploring GLP-1 treatment in the Philippines, three questions are more useful than a generic price list: Is the exact medicine registered for the relevant use? Who provides medical assessment? What will the complete course of care cost?
Local-language quick guide
Buod sa Filipino: Bago magpasya tungkol sa GLP-1 sa Pilipinas, tingnan ang rehistrasyon ng produkto at pasilidad sa FDA Verification Portal, kumpirmahin ang lisensiyadong doktor at humingi ng kumpletong tala ng bayarin sa piso. Hindi nito pinatutunayang aprubado o available ang anumang partikular na gamot.
The detailed guide below is currently in English. Other language editions require editorial review before publication.
Where to verify a GLP-1 medicine in the Philippines
The FDA Verification Portal is intended for checking establishments and certificates of product registration. Search for the exact product and registrant and confirm validity rather than relying on a social-media listing.
Open the official Philippines Food and Drug Administration (FDA) resource and keep the product name and registration details with the date checked. Search results can change, and a registration for one brand, indication or presentation should not be extended to another.
GLP-1 medicines are not a single interchangeable group. Semaglutide and tirzepatide have different receptor actions and can have different labels or permitted indications across markets. The WHO’s 2025 guideline discusses these therapies for adults with obesity as part of broader care, rather than a substitute for medical assessment.
Finding weight-management clinics
Our the Philippines clinic directory links to documented provider websites rather than asserting that every listed clinic offers a particular prescription. St. Luke’s Global City, St. Luke’s Quezon City and Chinese General Hospital are source-linked directory references; ask them directly about current weight-management services and referral arrangements.
A useful first contact should establish clinician qualifications, referral requirements, relevant examinations, ongoing reviews, the exact prescribing and dispensing pathway, and how to handle adverse effects or treatment changes.
Understanding GLP-1 costs in PHP
Check whether a quoted peso price covers specialist evaluation, diagnostics, medicine if prescribed and follow-up. A wellness promotion is not evidence of prescribing services or a currently registered medicine.
Request any applicable FDA product registration details, the provider’s licensed status, the clinician’s role and an itemised amount in Philippine pesos for consultation, tests and follow-up.
Use the GLP1Asia treatment cost calculator with quoted fees. It calculates a scenario from your entries; it is not a price database. You can also read how to compare treatment costs.
Which GLP-1 medicines should I compare?
Start with two research summaries: semaglutide in Asia and tirzepatide in Asia. They explain the medicine classes, common consultation questions and why brand registration must be checked country by country. The treatment comparison covers additional agents and research-stage compounds.
Frequently asked questions about GLP-1 in the Philippines
How do I verify a GLP-1 medicine in the Philippines?
Check the official register published by Philippines Food and Drug Administration (FDA), using the exact brand, active ingredient or registration number. A generic website mention is not proof of a specific current registration.
How much does GLP-1 care cost in the Philippines?
It depends on the provider and what is included. Ask for itemised consultation, diagnostics, follow-up and any medicine cost in PHP; a screening package is not a medicine price.
Can I find GLP-1 clinics in the Philippines?
GLP1Asia lists source-linked obesity or weight-management service references. Confirm with each provider whether a qualified clinician currently offers GLP-1 evaluation and which medicines, if any, are available.
Are semaglutide and tirzepatide the same?
No. Semaglutide acts at the GLP-1 receptor; tirzepatide acts at GIP and GLP-1 receptors. Indications, products, clinical decisions and country-specific registration are not interchangeable.
Does a clinic listing mean GLP1Asia has verified a doctor or product?
No. Listing links show a source for an organisation or service; they are not an independent licence audit or proof of prescribing availability.
How often is information about the Philippines checked?
Automated checks may detect website changes, with regulatory sources checked when due and some directory and price sources scheduled weekly. A successful fetch is not proof that clinical information or current product status has been verified.
Primary sources and next checks
- Philippines Food and Drug Administration (FDA) — official medicine or regulator information
- World Health Organization — 2025 GLP-1 obesity guideline
- MedlinePlus — semaglutide medicine information
- MedlinePlus — tirzepatide medicine information